Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
R-CVP 方案序贯利妥昔单抗维持治疗晚期边缘区淋巴瘤患者的 II 期研究:淋巴瘤生存改善联盟 (CISL) 研究
期刊:Cancer Communications
影响因子:24.9
doi:10.1186/s40880-019-0403-7
Oh, Sung Yong; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Yoon, Dok Hyun; Yang, Deok-Hwan; Lee, Won Sik; Kim, Hyo Jung; Yhim, Ho-Young; Jeong, Seong Hyun; Won, Jong Ho; Lee, Suee; Kong, Jee Hyun; Lim, Sung-Nam; Ji, Jun Ho; Kwon, Kyung A; Lee, Gyeong-Won; Lee, Jae Hoon; Lee, Ho Sup; Shin, Ho-Jin; Suh, Cheolwon